Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Nov-24 4:05 PM View:  | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 13-Nov-24 | Option Exercise | 30,625 | $2.90 | $88,714.50 | 10% 307.97K to 338.6K | |
| 15-Nov-24 4:05 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 13-Nov-24 | Planned Option Sale | 30,625 | $49.50 | $1,516,040.00 | (9%) 338.6K to 307.97K | |
| 11-Oct-24 4:05 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 09-Oct-24 | Option Exercise | 15,625 | $2.90 | $45,262.50 | 5% 307.97K to 323.6K | |
| 11-Oct-24 4:05 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 09-Oct-24 | Planned Option Sale | 15,625 | $38.24 | $597,568.00 | (5%) 323.6K to 307.97K | |
| 27-Sep-24 4:05 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 25-Sep-24 | Option Exercise | 23,125 | $2.90 | $66,988.50 | 8% 307.97K to 331.1K | |
| 27-Sep-24 4:05 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 25-Sep-24 | Planned Option Sale | 23,125 | $46.05 | $1,064,810.00 | (7%) 331.1K to 307.97K | |
| 20-Sep-24 4:45 PM View: | Seidenberg Beth C Director | Vera Therapeutics, Inc. (VERA) | 19-Sep-24 | Sale (Planned) | 13,823 | $42.31 | $584,793.00 | (8%) 164.39K to 150.56K | |
| 20-Sep-24 4:45 PM View: | Seidenberg Beth C Director | Vera Therapeutics, Inc. (VERA) | 18-Sep-24 | Private Sale (Planned) | 1,177 | $42.01 | $49,448.00 | (< 1%) 167.04K to 165.86K | |
| 20-Sep-24 4:45 PM View: | Seidenberg Beth C Director | Vera Therapeutics, Inc. (VERA) | 18-Sep-24 | Sale (Planned) | 1,476 | $42.00 | $61,992.00 | (< 1%) 165.86K to 164.39K | |
| 13-Sep-24 4:36 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 11-Sep-24 | Option Exercise | 15,625 | $2.90 | $45,262.50 | 5% 307.97K to 323.6K | |
| 13-Sep-24 4:36 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 11-Sep-24 | Planned Option Sale | 15,625 | $37.50 | $585,934.00 | (5%) 323.6K to 307.97K | |
| 30-Aug-24 4:04 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 28-Aug-24 | Option Exercise | 15,625 | $2.90 | $45,262.50 | 5% 322.67K to 338.29K | |
| 30-Aug-24 4:04 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 28-Aug-24 | Sale (Planned) | 14,695 | $36.85 | $541,437.00 | (5%) 322.67K to 307.97K | |
| 30-Aug-24 4:04 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 28-Aug-24 | Planned Option Sale | 15,625 | $36.85 | $575,703.00 | (5%) 338.29K to 322.67K | |
| 23-Aug-24 5:40 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 21-Aug-24 | Private Sale (Planned) | 14,471 | $39.76 | $575,425.00 | (4%) 337.14K to 322.67K | |
| 17-May-24 4:21 PM View: | Young Joseph R SVP, Finance, Chief Acct Offcr | Vera Therapeutics, Inc. (VERA) | 16-May-24 | Sale | 1,965 | $42.32 | $83,153.00 | (4%) 53.17K to 51.21K | |
| 17-May-24 4:21 PM View: | Young Joseph R SVP, Finance, Chief Acct Offcr | Vera Therapeutics, Inc. (VERA) | 16-May-24 | Option Exercise | 20,651 | $7.87 | $162,523.00 | 40% 51.21K to 71.86K | |
| 17-May-24 4:21 PM View: | Young Joseph R SVP, Finance, Chief Acct Offcr | Vera Therapeutics, Inc. (VERA) | 16-May-24 | Option Sale | 18,686 | $42.32 | $790,737.00 | (26%) 71.86K to 53.17K | |
| 17-May-24 4:21 PM View: | Young Joseph R SVP, Finance, Chief Acct Offcr | Vera Therapeutics, Inc. (VERA) | 15-May-24 | Option Exercise | 8,221 | $3.94 | $32,387.50 | 15% 53.17K to 61.39K | |
| 17-May-24 4:21 PM View: | Young Joseph R SVP, Finance, Chief Acct Offcr | Vera Therapeutics, Inc. (VERA) | 15-May-24 | Option Sale | 10,186 | $42.27 | $430,546.00 | (17%) 61.39K to 51.21K | |
| 12-Apr-24 4:02 PM View: | Young Joseph R SVP, Finance, Chief Acct Offcr | Vera Therapeutics, Inc. (VERA) | 10-Apr-24 | Private Sale | 5,714 | $40.00 | $228,560.00 | (10%) 58.88K to 53.17K | |
| 05-Apr-24 9:32 PM View: | Grant Sean Chief Financial Officer | Vera Therapeutics, Inc. (VERA) | 03-Apr-24 | Option Sale | 99,828 | $39.61 | $3,954,520.00 | (53%) 189.81K to 89.99K | |
| 05-Apr-24 9:32 PM View: | Grant Sean Chief Financial Officer | Vera Therapeutics, Inc. (VERA) | 03-Apr-24 | Sale | 18,649 | $39.42 | $735,205.00 | (21%) 89.99K to 71.34K | |
| 05-Apr-24 9:32 PM View: | Grant Sean Chief Financial Officer | Vera Therapeutics, Inc. (VERA) | 03-Apr-24 | Option Exercise | 99,828 | $14.87 | $1,484,440.00 | 111% 89.99K to 189.81K | |
| 25-Mar-24 9:46 PM View: | Katabi Maha Director | Vera Therapeutics, Inc. (VERA) | 25-Mar-24 | Sale | 340,000 | $40.50 | $13,770,000.00 | (11%) 3.13M to 2.79M | |
| 25-Mar-24 9:46 PM View: | Katabi Maha Director | Vera Therapeutics, Inc. (VERA) | 22-Mar-24 | Sale | 413,450 | $40.51 | $16,748,900.00 | (12%) 3.55M to 3.13M | |
| 25-Mar-24 9:46 PM View: | Katabi Maha Director | Vera Therapeutics, Inc. (VERA) | 21-Mar-24 | Private Sale | 81,009 | $44.20 | $3,580,720.00 | (2%) 3.63M to 3.55M | |
| 01-Feb-24 5:58 PM View: | Katabi Maha Director | Vera Therapeutics, Inc. (VERA) | 30-Jan-24 | Purchase | 161,290 | $31.00 | $4,999,990.00 | 5% 3.47M to 3.63M | |
| 18-Jan-24 4:06 PM View: | Young Joseph R SVP, Finance, Chief Acct Offcr | Vera Therapeutics, Inc. (VERA) | 16-Jan-24 | Grant | 21,875 | -- | -- | 62% 35.18K to 57.05K | |
| 18-Jan-24 4:54 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 16-Jan-24 | Grant | 78,750 | -- | -- | 31% 256.88K to 335.63K | |
| 18-Jan-24 4:03 PM View: | Grant Sean Chief Financial Officer | Vera Therapeutics, Inc. (VERA) | 16-Jan-24 | Grant | 26,250 | -- | -- | 42% 62.43K to 88.68K | |
| 12-Jan-24 9:55 PM View: | Commodore Capital Lp 10% Owner | Vera Therapeutics, Inc. (VERA) | 10-Jan-24 | Sale | 1,050,000 | $18.00 | $18,900,000.00 | (19%) 5.45M to 4.4M | |
| 03-Jan-24 4:15 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 29-Dec-23 | Option Exercise | 13,516 | $2.87 | $38,854.20 | 6% 243.36K to 256.88K | |
| 05-Apr-24 9:27 PM View: | Grant Sean Chief Financial Officer | Vera Therapeutics, Inc. (VERA) | 20-Dec-23 | Gift | 636 | -- | -- | (1%) 59.93K to 59.3K | |
| 23-Aug-23 5:56 PM View: | Fordyce Marshall President and CEO Director | Vera Therapeutics, Inc. (VERA) | 21-Aug-23 | Sale (Planned) | 5,210 | $16.66 | $86,778.80 | (2%) 248.57K to 243.36K | |
| 23-Aug-23 5:59 PM View: | Lin Celia Chief Medical Officer | Vera Therapeutics, Inc. (VERA) | 21-Aug-23 | Sale (Planned) | 1,490 | $16.65 | $24,815.50 | (12%) 12.5K to 11.01K | |
| 23-Aug-23 5:57 PM View: | Curley Joanne Chief Development Officer | Vera Therapeutics, Inc. (VERA) | 21-Aug-23 | Sale (Planned) | 1,490 | $16.66 | $24,817.10 | (5%) 28.45K to 26.96K | |
| 05-Apr-24 9:27 PM View: | Grant Sean Chief Financial Officer | Vera Therapeutics, Inc. (VERA) | 24-Jul-23 | Gift | 1,620 | -- | -- | (3%) 61.55K to 59.93K | |
| 05-Apr-24 9:27 PM View: | Grant Sean Chief Financial Officer | Vera Therapeutics, Inc. (VERA) | 24-Jul-23 | Gift | 1,620 | -- | -- | 3% 59.93K to 61.55K | |
| 06-Jul-23 4:05 PM View: | Young Joseph R SVP, Finance, Chief Acct Offcr | Vera Therapeutics, Inc. (VERA) | 05-Jul-23 | Option Exercise | 10,000 | $3.94 | $39,396.00 | 44% 22.68K to 32.68K | |
| 23-Jun-23 4:05 PM View: | Grant Sean Chief Financial Officer | Vera Therapeutics, Inc. (VERA) | 23-Jun-23 | Private Purchase | 5,000 | $16.60 | $83,000.00 | 9% 54.93K to 59.93K | |
| 22-Jun-23 4:10 PM View: | Commodore Capital Lp 10% Owner | Vera Therapeutics, Inc. (VERA) | 20-Jun-23 | Private Purchase | 448,217 | $15.17 | $6,799,000.00 | 9% 5.0M to 5.45M | |
| 03-Apr-23 4:05 PM View: | Seidenberg Beth C Director | Vera Therapeutics, Inc. (VERA) | 30-Mar-23 | Private Purchase | 2,300 | $7.24 | $16,650.80 | < 1% 1.95M to 1.95M | |
| 30-Mar-23 4:07 PM View: | Seidenberg Beth C Director | Vera Therapeutics, Inc. (VERA) | 28-Mar-23 | Private Purchase | 23,908 | $7.24 | $173,192.00 | 1% 1.92M to 1.95M | |
| 28-Mar-23 4:05 PM View: | Seidenberg Beth C Director | Vera Therapeutics, Inc. (VERA) | 27-Mar-23 | Purchase | 1,633 | $7.24 | $11,830.30 | < 1% 3.84M to 3.84M | |
| 28-Mar-23 4:05 PM View: | Seidenberg Beth C Director | Vera Therapeutics, Inc. (VERA) | 24-Mar-23 | Private Purchase | 1,833 | $7.24 | $13,271.80 | < 1% 3.84M to 3.84M | |
| 21-Mar-23 4:40 PM View: | Seidenberg Beth C Director | Vera Therapeutics, Inc. (VERA) | 20-Mar-23 | Purchase | 15,252 | $7.21 | $110,033.00 | < 1% 3.81M to 3.82M | |
| 21-Mar-23 4:40 PM View: | Seidenberg Beth C Director | Vera Therapeutics, Inc. (VERA) | 17-Mar-23 | Private Purchase | 74,045 | $7.12 | $526,882.00 | 2% 3.73M to 3.81M | |
| 17-Mar-23 4:10 PM View: | Seidenberg Beth C Director | Vera Therapeutics, Inc. (VERA) | 16-Mar-23 | Purchase | 60,097 | $7.09 | $426,268.00 | 2% 3.54M to 3.6M | |
| 17-Mar-23 4:10 PM View: | Seidenberg Beth C Director | Vera Therapeutics, Inc. (VERA) | 15-Mar-23 | Private Purchase | 32,844 | $7.12 | $234,010.00 | < 1% 3.51M to 3.54M |
